Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Colorectal Cancer Stage IVColorectal Cancer MetastaticColorectal Cancer, Genetics ofAppendix Cancer

Interventions

DIAGNOSTIC_TEST

prospective single arm biomarker (plasma cell-free DNA hydroxymethylation) study

Blood draw

Trial Locations (1)

The University of Chicago, Chicago

All Listed Sponsors

lead

University of Chicago

OTHER

NCT04157322 - Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis | Biotech Hunter | Biotech Hunter